{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:54:16Z","timestamp":1762102456762,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003331","name":"Provincial Health Services Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.placenta.2019.12.016","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T11:23:18Z","timestamp":1577100198000},"page":"118-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Altered level of salivary placental growth factor is associated with preeclampsia"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1916-1328","authenticated-orcid":false,"given":"Shannon L.","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada","family":"Taymoori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David T.W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-8468","authenticated-orcid":false,"given":"Jill L.","family":"Maron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.placenta.2019.12.016_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1053\/j.semperi.2009.02.010","article-title":"The global impact of pre-eclampsia and eclampsia","volume":"33","author":"Duley","year":"2009","journal-title":"Semin. Perinatol."},{"issue":"3","key":"10.1016\/j.placenta.2019.12.016_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/jp.2015.170","article-title":"Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia","volume":"36","author":"Honigberg","year":"2016","journal-title":"J. Perinatol."},{"issue":"4","key":"10.1016\/j.placenta.2019.12.016_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.preghy.2015.09.004","article-title":"Accuracy of angiogenic biomarkers at 20 weeks' gestation in predicting the risk of pre-eclampsia: a WHO multicentre study","volume":"5","author":"Widmer","year":"2015","journal-title":"Pregnancy. Hypertens."},{"key":"10.1016\/j.placenta.2019.12.016_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.placenta.2017.01.119","article-title":"Review: placental derived biomarkers of pregnancy disorders","volume":"54","author":"Cuffe","year":"2017","journal-title":"Placenta"},{"issue":"5","key":"10.1016\/j.placenta.2019.12.016_bib5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1373\/clinchem.2011.169094","article-title":"The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia","volume":"58","author":"Hagmann","year":"2012","journal-title":"Clin. Chem."},{"issue":"4","key":"10.1016\/j.placenta.2019.12.016_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.116.08620","article-title":"Prediction of preeclampsia using the soluble fms-like tyrosine kinase 1 to placental growth factor ratio: a prospective cohort study of unselected nulliparous women","volume":"69","author":"Sovio","year":"2017","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2019.12.016_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/pd.4519","article-title":"First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors","volume":"35","author":"Crovetto","year":"2015","journal-title":"Prenat. Diagn."},{"issue":"11","key":"10.1016\/j.placenta.2019.12.016_bib8","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1097\/HJH.0b013e328357c0c9","article-title":"Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia","volume":"30","author":"Leanos-Miranda","year":"2012","journal-title":"J. Hypertens."},{"issue":"Suppl 1","key":"10.1016\/j.placenta.2019.12.016_bib9","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/S0049-3848(15)50435-0","article-title":"The role of extracellular vesicles in placental vascular complications","volume":"135","author":"Aharon","year":"2015","journal-title":"Thromb. Res."},{"issue":"6","key":"10.1016\/j.placenta.2019.12.016_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098667","article-title":"A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migrations","volume":"9","author":"Salomon","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.placenta.2019.12.016_bib11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.oraloncology.2012.01.021","article-title":"Saliva: a potential media for disease diagnostics and monitoring","volume":"48","author":"Liu","year":"2012","journal-title":"Oral Oncol."},{"key":"10.1016\/j.placenta.2019.12.016_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3389\/fpubh.2017.00077","article-title":"Saliva liquid biopsy for point-of-care applications","volume":"5","author":"Aro","year":"2017","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.placenta.2019.12.016_bib13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/pd.4811","article-title":"Placental biomarkers and angiogenic factors in oral fluids of patients with preeclampsia","volume":"36","author":"Chaparro","year":"2016","journal-title":"Prenat. Diagn."},{"key":"10.1016\/j.placenta.2019.12.016_bib14","first-page":"e1","article-title":"Practice bulletin No. 202. Gestational hypertension and preeclampsia","volume":"133","author":"ACOG","year":"2019","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2019.12.016_bib15","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2144\/000114254","article-title":"RNAPro*SAL: a device for rapid and standardized collection of saliva RNA and proteins","volume":"58","author":"Chiang","year":"2015","journal-title":"Biotechniques"},{"issue":"1","key":"10.1016\/j.placenta.2019.12.016_bib16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s12884-016-1169-4","article-title":"First trimester serum placental growth factor and hyperglycosylated human chorionic gonadotropin are associated with pre-eclampsia: a case control study","volume":"16","author":"Keikkala","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"7","key":"10.1016\/j.placenta.2019.12.016_bib17","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and metal-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.placenta.2019.12.016_bib18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1097\/01.AOG.0000264552.85436.a1","article-title":"Placental growth factor and soluble fms-like tyrosine kinase-1 in early-onset and late-onset preeclampsia","volume":"109","author":"Wikstrom","year":"2007","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.placenta.2019.12.016_bib19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1291\/hypres.30.151","article-title":"Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia","volume":"30","author":"Ohkuchi A Hirashima","year":"2007","journal-title":"Hypertens. Res."},{"issue":"1","key":"10.1016\/j.placenta.2019.12.016_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jama.293.1.77","article-title":"Urinary placental growth factor and risk of preeclampsia","volume":"293","author":"Levine","year":"2005","journal-title":"J. Am. Med. Assoc."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400419307271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400419307271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:01:16Z","timestamp":1758909676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400419307271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":20,"alternative-id":["S0143400419307271"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2019.12.016","relation":{},"ISSN":["0143-4004"],"issn-type":[{"type":"print","value":"0143-4004"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered level of salivary placental growth factor is associated with preeclampsia","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2019.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}